Background Most liver transplant recipients receive either cyclosporin or tacrolimus to prevent rejection. Both drugs inhibit calcineurin phosphatase which is thought to be the mechanism of their anti-rejection effect and principle toxicities. The drugs have different pharmacokinetic profiles and po...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!